C-14Government of CanadaLIBERAL
Pharmacare Implementation Act, Phase 2
Tests whether the NDP-Liberal pharmacare framework survives the change in NDP leadership and the post-2025 election arithmetic.
Status
✓
Introduced✓
1st Reading3
2nd Reading4
Committee5
Report6
3rd Reading7
Royal AssentSummary
Expands the first-phase universal pharmacare framework from C-64 (2024) to include reproductive-health and chronic-disease essential medicines. Adds a federal-provincial pharmacare commissioner.
Sponsored by
Adam van KoeverdenLIBERAL